Roivant Sciences LTD Form 4 insider transactions

Director Ilan Oren reports acquisition and disposal of Roivant Sciences Ltd. common shares related to director compensation and tax obligations.

Rakhi Kumar, Chief Accounting Officer of Roivant Sciences, disposed of 958 common shares to cover tax withholding obligations related to vested RSUs.

Director James C. Momtazee of Roivant Sciences Ltd. reports the acquisition of 1,555 common shares as part of the company's Non-Employee Director Compensation Plan.

Director Melissa Epperly received 1,702 common shares of Roivant Sciences Ltd. as part of the company's Non-Employee Director Compensation Plan.

Richard Pulik, CFO of Roivant Sciences Ltd., reports the disposal of 2,340 common shares to cover tax obligations related to vested RSUs.

Richard Pulik, CFO of Roivant Sciences Ltd., disposed of 2,129 common shares on June 20, 2024, to cover tax obligations related to vested RSUs.

Rakhi Kumar, Chief Accounting Officer of Roivant Sciences, reports a transaction involving the disposal of shares to cover tax obligations related to vested RSUs.

Eric Venker, President & COO of Roivant Sciences, disposed of 10,945 common shares to cover tax obligations related to vested RSUs.

Roivant Sciences CEO Matthew Gline disposed of 10,945 common shares on June 20, 2024, to cover tax withholding obligations related to vested RSUs.

Richard Pulik, CFO of Roivant Sciences Ltd., disposed of 2,341 common shares on May 28, 2024, to cover tax withholding obligations related to the vesting and settlement of RSUs.

Eric Venker, President & COO of Roivant Sciences, disposed of 16,003 common shares to cover tax obligations related to vested RSUs.

Rakhi Kumar, Chief Accounting Officer of Roivant Sciences, reports a transaction involving common shares to cover tax obligations related to vested RSUs.

Matthew Gline, CEO of Roivant Sciences, disposed of 10,945 common shares on May 20, 2024, to cover tax withholding obligations related to vested RSUs.

Richard Pulik, CFO of Roivant Sciences, reports a transaction involving the disposal of common shares to cover tax withholding obligations related to vested RSUs.

Director Meghan Fitzgerald reports acquisition of shares and disposition of shares to cover tax obligations related to vesting of previously granted shares.

Director James C. Momtazee reports acquisition and disposal of Roivant Sciences Ltd. common shares related to a restricted stock award and tax obligations.

Director Ilan Oren reports acquisition and disposal of Roivant Sciences Ltd. common shares related to director compensation and tax obligations.

Director Melissa Epperly reports acquisition and disposal of Roivant Sciences Ltd. common shares related to director compensation and tax obligations.

Rakhi Kumar, Chief Accounting Officer of Roivant Sciences Ltd., reports the acquisition of common shares and stock options.

Richard Pulik, CFO of Roivant Sciences, reports the acquisition of restricted stock units and stock options.

Matthew Gline, CEO of Roivant Sciences, disposed of 10,945 common shares on April 20, 2024, to cover tax withholding obligations related to vested RSUs.

Richard Pulik, CFO of Roivant Sciences, disposed of 8,515 common shares to cover tax obligations related to vested RSUs.

Rakhi Kumar, Chief Accounting Officer of Roivant Sciences, disposed of 9,881 common shares to cover tax obligations related to vested RSUs.

Eric Venker, President & COO of Roivant Sciences, disposed of 16,002 common shares on April 20, 2024, to cover tax obligations related to RSU vesting.

Richard Pulik, CFO of Roivant Sciences Ltd., reports the disposal of 2,341 common shares to cover tax obligations related to vested RSUs on March 28, 2024.

Mayukh Sukhatme, President and Chief Investment Officer of Roivant Sciences, settled capped value appreciation rights (CVARs) for common shares and reported tax withholding transactions.

Roivant Sciences CEO Matthew Gline converted capped value appreciation rights (CVARs) into common shares and had shares withheld for tax obligations on March 30, 2024.

Eric Venker, President & COO of Roivant Sciences, disposed of 16,003 common shares to cover tax obligations related to vested RSUs.

Rakhi Kumar, Chief Accounting Officer of Roivant Sciences Ltd., reports a transaction involving common shares to cover tax obligations related to vested RSUs.

Roivant Sciences CEO Matthew Gline disposed of 10,945 common shares on March 20, 2024, to cover tax withholding obligations related to the vesting and settlement of RSUs.